Brief: Advaxis Says On Oct 6 Co Received Notice From Aratana Therapeutics Dated Sept 17 Indicating That Aratana Terminating Exclusive License Agreement Dated March 19 2014

Ayala Pharmaceuticals

08/10/2020 12:14

Oct 8 (Reuters) - Advaxis Inc  ADXS.O :
    * ADVAXIS - ON OCT 6, CO RECEIVED NOTICE FROM ARATANA
THERAPEUTICS, DATED SEPT 17, INDICATING THAT ARATANA TERMINATING
EXCLUSIVE LICENSE AGREEMENT, DATED MARCH 19, 2014
    * ADVAXIS SAYS TERMINATION OF LICENSE AGREEMENT WITH ARATANA
THERAPEUTICS WILL BE EFFECTIVE ON DECEMBER 21, 2020 - SEC FILING
    * ADVAXIS SAYS CO WILL NOT INCUR ANY EARLY TERMINATION
PENALTIES
AS A RESULT OF LICENSE AGREEMENT TERMINATION WITH ARATANA
THERAPEUTICS

Source text:[https://bit.ly/33FNHkw]
Further company coverage:  ADXS.O 

 ((Reuters.Briefs@thomsonreuters.com;))